Open-Label,Non-Randomized Trial of Cisplatin Chemotherapy in BRCA1-Positive Metastatic Breast Cancer Patients

Clinical trial NCT01611727 · COMPLETED

Trial details

NCT number: NCT01611727
Sponsor: Pomeranian Medical University Szczecin
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

BRCA1 Mutation Metastatic Breast Cancer

Start date: 2007-07-01
Primary completion: 2009-01-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.